Quimbaya Gold Confirms Presence of a Copper-Molybdenum Porphyry System at Tahami Center

Quimbaya Gold completed six drill holes totaling 2,927.9 meters at its Tahami Center copper-molybdenum target in Colombia, with all holes intersecting the modeled porphyry system. The deepest hole, TCDH-006, encountered approximately 563 meters of potassic alteration and 150 meters of principal intramineral porphyry, with visually logged chalcopyrite and molybdenite veinlets reaching 50-60 per meter. No assays or grades have been reported, mineralization is described as variable and in places marginal, and laboratory results are expected in late September or October 2026.

Analysis

This is an assay-driven microcap optionality event, not yet a de-risking event. The geological architecture increases the probability that follow-up drilling can vector toward a higher-grade center, but neither visual sulfides nor vein density establishes copper-equivalent grade, metallurgy, continuity, strip ratio, or economic scale. The relevant repricing window is late September through October: a credible broad intercept at grades sufficient to support a Colombian porphyry development concept could drive a sharp retail-led rerating, while subeconomic grades would likely erase any pre-assay bid quickly.

The more actionable signal is the likely liquidity dynamic: paid awareness activity runs directly into the assay window, which can amplify volume and widen the gap between promotional momentum and fundamental value. That raises execution risk for QIM/QIMGF and makes chasing strength unattractive without verified assays, current cash balance, monthly burn, fully diluted share count, and warrant overhang. SGSN has no meaningful earnings sensitivity; laboratory sample throughput from a single junior program is immaterial.

Over 6-18 months, even a positive assay would create financing rather than production value: defining a porphyry target requires materially more drilling, technical work, permitting progress, and repeated equity capital. The key falsifier of a bullish interpretation is not one isolated high-grade interval but whether multiple holes demonstrate coherent grade-thickness around the modeled core and management can fund the next campaign without a heavily discounted raise. Consensus retail enthusiasm may underprice dilution and jurisdictional/social-license risk, while bears may underprice the value of a genuine district-scale discovery if assays show both grade and lateral continuity.

Key Decisions for Investors

• No core position before assays. Place QIMGF/QIM on an event-driven watchlist for late-September to October results; act only if reported assays show repeatable copper-equivalent grade-thickness across multiple holes, not a single visual or selective interval.
• If assays validate continuity, use a small long QIMGF position only after the initial liquidity spike settles, with a 1-3 month catalyst horizon tied to follow-up drilling and financing clarity. Size as venture optionality because a failed assay can plausibly produce a 40%+ drawdown in an illiquid junior.
• Avoid buying promotional strength during the September-November marketing campaign unless daily liquidity, fully diluted capitalization, cash runway, and warrant schedule support an orderly exit. The promotion/assay overlap is a potential distribution window rather than independent validation.
• For a bullish post-assay trade, require management to disclose remaining cash sufficient for the next drill phase or a financing at limited discount; a deeply discounted placement, large warrant package, or assay results showing predominantly marginal mineralization would invalidate the thesis.
• Do not express this through SGSN: any incremental SGS assay revenue is economically immaterial relative to its global testing business, and the ticker has no tradeable linkage to Quimbaya's discovery outcome.